150 related articles for article (PubMed ID: 19058854)
1. cAMP regulates IL-10 production by normal human T lymphocytes at multiple levels: a potential role for MEF2.
Liopeta K; Boubali S; Virgilio L; Thyphronitis G; Mavrothalassitis G; Dimitracopoulos G; Paliogianni F
Mol Immunol; 2009 Jan; 46(3):345-54. PubMed ID: 19058854
[TBL] [Abstract][Full Text] [Related]
2. Calcium/calmodulin-dependent protein kinase II regulates IL-10 production by human T lymphocytes: a distinct target in the calcium dependent pathway.
Boubali S; Liopeta K; Virgilio L; Thyphronitis G; Mavrothalassitis G; Dimitracopoulos G; Paliogianni F
Mol Immunol; 2012 Sep; 52(2):51-60. PubMed ID: 22578382
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells.
Tokoyoda K; Tsujikawa K; Matsushita H; Ono Y; Hayashi T; Harada Y; Abe R; Kubo M; Yamamoto H
Int Immunol; 2004 May; 16(5):643-53. PubMed ID: 15096485
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway.
Borger P; Kauffman HF; Postma DS; Vellenga E
Blood; 1996 Jan; 87(2):691-8. PubMed ID: 8555492
[TBL] [Abstract][Full Text] [Related]
5. Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A.
Staples KJ; Bergmann M; Tomita K; Houslay MD; McPhee I; Barnes PJ; Giembycz MA; Newton R
J Immunol; 2001 Aug; 167(4):2074-80. PubMed ID: 11489990
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 differentially modulates IL-5 gene expression in activated human T lymphocytes depending on the costimulatory signal.
Borger P; Vellenga E; Gringhuis SI; Timmerman JA; Lummen C; Postma DS; Kauffman HF
J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):231-40. PubMed ID: 9500757
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP sensitive signalling by the CD28 marker requires concomitant stimulation by the T-cell antigen receptor (TCR/CD3) complex.
Skålhegg BS; Rasmussen AM; Taskén K; Hansson V; Jahnsen T; Lea T
Scand J Immunol; 1994 Aug; 40(2):201-8. PubMed ID: 8047842
[TBL] [Abstract][Full Text] [Related]
8. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
Laxminarayana D; Kammer GM
J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
[TBL] [Abstract][Full Text] [Related]
9. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Hess AD; Bright EC
Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
[TBL] [Abstract][Full Text] [Related]
10. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
Bartik MM; Bauman GP; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
[TBL] [Abstract][Full Text] [Related]
11. Prevention of TCR-mediated apoptosis by the elevation of cAMP.
Hoshi S; Furutani-Seiki M; Seto M; Tada T; Asano Y
Int Immunol; 1994 Jul; 6(7):1081-9. PubMed ID: 7947459
[TBL] [Abstract][Full Text] [Related]
12. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
[TBL] [Abstract][Full Text] [Related]
13. cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression.
Grader-Beck T; van Puijenbroek AA; Nadler LM; Boussiotis VA
Blood; 2003 Feb; 101(3):998-1006. PubMed ID: 12393539
[TBL] [Abstract][Full Text] [Related]
14. Myocyte enhancer factor 2 mediates calcium-dependent transcription of the interleukin-2 gene in T lymphocytes: a calcium signaling module that is distinct from but collaborates with the nuclear factor of activated T cells (NFAT).
Pan F; Ye Z; Cheng L; Liu JO
J Biol Chem; 2004 Apr; 279(15):14477-80. PubMed ID: 14722108
[TBL] [Abstract][Full Text] [Related]
15. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE
J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699
[TBL] [Abstract][Full Text] [Related]
16. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R
Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506
[TBL] [Abstract][Full Text] [Related]
17. Involvement of protein kinase A in histamine-mediated inhibition of IL-2 mRNA expression in mouse splenocytes.
Poluektova LY; Huggler GK; Patterson EB; Khan MM
Immunopharmacology; 1999 Feb; 41(2):77-87. PubMed ID: 10102790
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the T-cell activation signaling pathway mediated by tyrosine kinases, protein kinase C, and Ras protein, which is modulated by intracellular cyclic AMP.
Ohtsuka T; Kaziro Y; Satoh T
Biochim Biophys Acta; 1996 Feb; 1310(2):223-32. PubMed ID: 8611637
[TBL] [Abstract][Full Text] [Related]
19. Cholera toxin enhances interleukin-17A production in both CD4
Tsai HC; Velichko S; Lee S; Wu R
Immunology; 2018 Jul; 154(3):500-509. PubMed ID: 29377102
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
